Judge Allows Plaintiff in Gadolinium-Based Contrast Agent Case to Amend Complaint



DOCUMENTS
  • Order


BOSTON — A Massachusetts federal judge has allowed a plaintiff to amend his complaint in a lawsuit targeting Bayer’s gadolinium-based contrast agent (GBCA), after ruling that the complaint is preempted because it did not cite any newly acquired information that would have allowed Bayer to change its label.

In a Sept. 30 order, Judge Indira Talwani of the U.S. District Court for the District of Massachusetts further ruled that the plaintiff adequately pled that Magnevist caused his injuries.

In 2010, Plaintiff Stephen Goodell was administered an injection of Bayer’s Magnevist, a GBCA, before undergoing an MRI. Goodell alleges that the …

FIRM NAMES
  • Andrus Wagstaff
  • Cutter Law
  • Drinker Biddle & Reath
  • Eckert Seamans Cherin & Mellott
  • Goldman Ismail Tomaselli Brennan & Baum





UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Video Game Addiction Product Liability Litigation

March 29, 2024

MORE DETAILS



HarrisMartin's Masters of Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS